AEROVANCE
Aerovance is a privately held biopharmaceutical company exclusively focused on developing and commercializing breakthrough medicines for respiratory and allergic diseases. The company maintains a solid intellectual property position with its strong portfolio of novel therapeutic candidates now in clinical development and several pre-clinical programs. The two lead products are human recombinant proteins: Aerovantâ„¢, an IL-4 and -13 receptor antagonist which is in Phase IIa studies for asthma and Aerodermâ„¢, a PEGylated IL-4 and IL-13 receptor antagonist in pre-clinical studies for eczema.
AEROVANCE
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2004-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.aerovance.com
Total Employee:
11+
Status:
Closed
Total Funding:
152.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon OpenResty AdBlock Acceptable Ads Bodis DNS
Founder
Investors List
Clarus Ventures
Clarus Ventures investment in Venture Round - Aerovance
Burrill & Company
Burrill & Company investment in Venture Round - Aerovance
Alta Partners
Alta Partners investment in Venture Round - Aerovance
Apax Partners
Apax Partners investment in Venture Round - Aerovance
BB Biotech Ventures
BB Biotech Ventures investment in Venture Round - Aerovance
Lehman Brothers
Lehman Brothers investment in Venture Round - Aerovance
ProQuest Investments
ProQuest Investments investment in Venture Round - Aerovance
NGN Capital
NGN Capital investment in Venture Round - Aerovance
Comerica Incorporated
Comerica Incorporated investment in Debt Financing - Aerovance
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Aerovance
Official Site Inspections
http://www.aerovance.com
- Host name: a904c694c05102f30.awsglobalaccelerator.com
- IP address: 76.223.54.146
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
